Skip to main content
SpringerLink
Log in

Immune regulation by CD8+ Treg cells: novel possibilities for anticancer immunotherapy

  • Research Highlight
  • Published:
Cellular & Molecular Immunology Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Wang, H., Franco, F. & Ho, P. C. Metabolic regulation of tregs in cancer: opportunities for immunotherapy. Trends Cancer 3, 583–592 (2017).

    Article  CAS  Google Scholar 

  2. Tanaka, A. & Sakaguchi, S. Regulatory T cells in cancer immunotherapy. Cell Res. 27, 109–118 (2017).

    Article  CAS  Google Scholar 

  3. Kiniwa, Y. et al. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer. Clin. Cancer Res. 13, 6947–6958 (2007).

    Article  CAS  Google Scholar 

  4. Chen, C. et al. Changes of CD4+ CD25+ FOXP3+ and CD8+ CD28 − regulatory T cells in non-small cell lung cancer patients undergoing surgery. Int. Immunopharmacol. 18, 255–261 (2014).

    Article  CAS  Google Scholar 

  5. Chaput, N. et al. Identification of CD8+ CD25+ Foxp3+ suppressive T cells in colorectal cancer tissue. Gut 58, 520–529 (2009).

    Article  CAS  Google Scholar 

  6. Zhang, S. et al. Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible mechanism for immune impairment. Cell. Mol. Immunol. 12, 580–591 (2015).

    Article  CAS  Google Scholar 

  7. Csencsits, K., Wood, S. C., Lu, G. & Bishop, D. K. Transforming growth factor-beta1 gene transfer is associated with the development of regulatory cells. Am. J. Transplant. 5, 2378–2384 (2005).

    Article  CAS  Google Scholar 

  8. WangQ, Yu. T. et al. Sorafenib reduces hepatic infiltrated regulatory T cells in hepatocellular carcinoma patients by suppressing TGF-beta signal. JSurg. Oncol 107, 422–427 (2013).

    Google Scholar 

  9. Wu, M. et al. TGF-beta1 contributes to CD8+ Treg induction through p38 MAPK signaling in ovarian cancer microenvironment. Oncotarget 7, 44534–44544 (2016).

    PubMed  Google Scholar 

  10. Palomares, O. et al. Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-beta. Genes Immun. 15, 511–520 (2014).

    Article  CAS  Google Scholar 

  11. Wu, M. et al. Gene expression profiling of CD8+ T cells induced by ovarian cancer cells suggests a possible mechanism for CD8+ Treg cell production. Cell. Prolif. 49, 669–677 (2016).

    Article  CAS  Google Scholar 

  12. Chen, Z. et al. CD11c(high)CD8+ regulatory T cell feedback inhibits CD4 T cell immune response via Fas ligand-Fas pathway. J. Immunol. 190, 6145–6154 (2013).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We are grateful to the technical support from National Key Clinical Department of Laboratory Medicine of Jiangsu Province Hospital. This study was supported by Natural Science Foundation of China (No.81772779), Jiangsu Province’sKey Provincial Talents Program (No. ZDRCA2016003) and Key Laboratory for Medicine of Jiangsu Province of China (No. ZDXKB2016005), a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.

Author information

Author notes

  1. S. Zhang and M. Wu contributed equally to this work.

Authors and Affiliations

  1. Department of Laboratory Medicine, Children’s Hospital of Nanjing Medical University, Nanjing, 210008, China

    Shuping Zhang & Meng Wu

  2. Department of Laboratory Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China

    Fang Wang

  3. National Key Clinical Department of Laboratory Medicine, Nanjing, 210029, China

    Fang Wang

Authors
  1. Shuping Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Meng Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fang Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fang Wang.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, S., Wu, M. & Wang, F. Immune regulation by CD8+ Treg cells: novel possibilities for anticancer immunotherapy. Cell Mol Immunol 15, 805–807 (2018). https://doi.org/10.1038/cmi.2018.170

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/cmi.2018.170

  • Springer Nature Limited

Keywords

This article is cited by

Search

Navigation